Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Stefano Gelibter MD

Stefano Gelibter MD

Neurologist, Department of Neurosciences, Neurology and Stroke Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

Stefano Gelibter, MD, is a neurologist and neuroimmunologist at the Department of Neurology and Stroke Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy. He completed his training in neurology and neuroimmunology at Vita-Salute San Raffaele University in Milan. Dr. Gelibter has focused his clinical and research activities on neuroimmunological diseases, with particular expertise in multiple sclerosis, neuromyelitis optica spectrum disorder, and MOG antibody-associated disease. His previous research explored novel biomarkers in these diseases, with a special focus on myeloid-derived extracellular vesicles. Currently, his work is mainly centered on the cognitive aspects of neuroimmunological diseases and the impact of aging and immunosenescence in these patient populations.

Disclosures

Dr. Gelibter reports the following:

  • Advisory board/Consulting/speaking fees: Novartis; Jannsen; Amgen
  • Research support: Roche